these immunoprecipitates for proteins previously shown to activate PLD1 in vitro.
only recognizes ARF1-5 and not ARF6, we probed the for ARF6 and found ARF6 immunoreactivity in the PLD1 immunoprecipitates but only after Fc␥RI aggregation (Figure 1b ). This data indicates that aggregation of Fc␥RI results in the association of PLD1 with ARF6 and PKC␣
Results and discussion
Functional coupling of Fc␥RI activation by immune combut not ARF1-5 or Rho. The time course of the association of PLD1 to ARF6 was similar to that observed for plexes to phospholipase D (PLD) has previously been demonstrated in interferon-␥ (IFN-␥)-primed U937 cells PKC␣ and strongly suggests that both these proteins are involved in coupling Fc␥RI activation to PLD1.
[4], and, here, this pathway has been exploited to explore with PKC␣ and ARF6. Following aggregation of Fc␥RI, cells were (a) Western blot analysis of PLD1 immunoprecipitated from the harvested at given time points, lysed, and PLD1 was immunoprecipitated nuclear (Triton X-100 insoluble) and nuclear-free membrane (Triton from these whole-cell lysates. These immunoprecipitates were soluble) fractions following Fc␥RI aggregation in IFN-␥-primed U937 electrophoresed through 12% acrylamide, and, following transfer cells. Numbers refer to the time after activation of Fc␥RI. Both fractions to nitrocellulose, the blots were probed for the presence of either were also probed for the presence of actin. The results shown are PKC␣ or ARF6, using specific monoclonal antibodies.
Our finding here that ARF6 associates with PLD1 is conletional analysis has demonstrated that the amino-terminal region of PLD1 is required for this direct activation sistent with emerging evidence that points to a role for ARF6 and not ARF1 as the factor that regulates PLD1 by PKC␣, presumably through protein:protein interactions [6] . Here, we have shown for the first time a physical in intact cells [16] . However, the absence of Rho in this study is surprising, as this factor has previously been conassociation of PLD1 and PKC␣ following receptor activation in intact cells. sidered the major factor involved in regulating PLD1. Rho has been proposed to synergize with PKC to maximally stimulate PLD1 by G protein-coupled receptors and to This association of PKC␣ with PLD1 was independent synergize with ARF during fMLP and muscarinic signalof either PKC kinase activity or the generation of phosing [6, 12, 14, 15] . These previous reports studied recepphatidic acid by PLD activity, as pretreating cells either tors that are seven-transmembrane domain receptors. In with PKC inhibitors, bisindolymaleimide I (50 nM) or this study, Fc␥RI is an immune receptor that is coupled Ro-31-8220 (50 nM), two different PKC inhibitors, or with to signaling cascades through the activation of soluble 0.3% butan-1-ol had no effect on this association (data tyrosine kinases by the recruitment of the immunorecepnot shown). Furthermore, Fc␥RI-stimulated PLD activity tor tyrosine activation motif of the ␥ chain [17] . It is was found to be upstream of PKC activity. Thus, in cells possible that the previously reported critical role of Rho treated with bisindolymaleimide I (50 nM) or Ro-31-8220 is a feature for seven-transmembrane receptors and that (50 nM), Fc␥RI activation of PLD was completely unafRho plays a lesser role in coupling receptors that signal fected, even at concentrations which completely ablated through tyrosine kinases.
the normal rise in PKC (Figure 2a ,b). Despite the lack of effect of kinase inhibitors, PKC␣ is required for receptor coupling to PLD activation, as downregulation of PKC␣ The relationship of PKC to the activation of PLD has been controversial. Phorbol esters are widely used to actiby either phorbol esters or specific antisense treatment reduced the ability of Fc␥RI to activate PLD (Figure vate PLD in cells, and the PKC inhibitor calphostin C inhibits activation of PLD. However, as calphostin C has 2c,d). We have previously shown that U937 cells are sensitive to antisense manipulation [17] . Taken together, these recently been reported to directly inhibit PLD, this has cast doubt on these observations [6] . In vitro studies have data indicate that both the association of PKC␣ with PLD1 and the measured increase in PLD activity after shown that PKC␣ activates PLD1 through its regulatory domain in a nucleotide-independent manner [6, 11]. Dereceptor aggregation depend on PKC␣ but is independent of PKC kinase activity, supporting the concept that PLD generated by crosstalk between ARF6 and PKC␣ independent of PKC kinase activity. is regulated through a physical interaction with PKC␣ and rather than kinase activity. These data imply that coupling of Fc␥RI to PLD1 activation requires signals
In IFN-␥-primed U937 cells, Fc␥RI is known to be cou- inhibited the translocation of PKC isoforms to the nuclear-free (b) Western blot analysis of PKC␦, -⑀, and -isoenzymes in the nuclearmembrane fraction following Fc ␥ RI aggregation, whereas free membrane fraction. Cells were pretreated with either 0.3% butandownregulation of PLD2 did not. Cells were harvested at various times 1-ol or 0.3% butan-2-ol for 20 min prior to receptor aggregation.
after receptor aggregation, lysed, and the nuclear-free membrane fraction Cells were harvested at various times after receptor aggregation, lysed, was prepared. After SDS-PAGE and transfer to nitrocellulose, the and the nuclear-free membrane fraction prepared. After SDS-PAGE blots were probed with monoclonal antibodies against the three and transfer to nitrocellulose, the blots were probed with monoclonal PKC isoforms previously identified to translocate following Fc␥RI antibodies against the three PKC isoforms previously identified to aggregation, namely, PKC␦, -⑀, and -. Control, untreated cells; translocate following Fc␥RI aggregation, namely, PKC␦, -⑀, and -[8].
a.s.PLD1, treatment with antisense to PLD1; a.s.PLD2, treatment with The results shown are typical from three separate experiments. (c)
antisense to PLD2. The results shown are typical from three separate Downregulation of PLD1 by antisense treatment inhibited the activation experiments of PKC following Fc ␥ RI aggregation, whereas downregulation of pled to an increase in PKC activity that is calcium indewas measured following Fc␥RI aggregation in cells pretreated with either butan-1-ol (0.3%) or with butan-2-ol pendent but lipid dependent, and the isozymes ␦, ⑀, and have been shown to translocate to the membrane, follow-(0.3%). Butan-1-ol but not butan-2-ol can act as an acceptor for the phosphatidyl moiety, thereby generating ing receptor aggregation by immune complexes [8] . Having shown that PKC kinase activity is not required to phosphatidyl butanol instead of phosphatidic acid [4] . As butan-2-ol cannot act as an acceptor, it serves as a control couple Fc␥RI to PLD activation, we next investigated the dependence of PKC activation on the generation of for nonspecific effects of the alcohol. Activation of PKC was abolished in cells treated with 0.3% butan-1-ol but phosphatidic acid following PLD activation. PKC activity not in those treated with 0.3% butan-2-ol (Figure 3a) .
antisense oligonucleotide, therefore, acted as an internal control for the other. These data indicate that PLD is necessary for the coupling of Fc␥RI to the activation of PKC and that, perhaps surprisingly, all Fc␥RI-stimulated PKC activity lies downSpecific downregulation of PLD1 by treating cells with stream of PLD activation.
the antisense to PLD1 attenuated Fc␥RI-coupled PKC activity ( Figure 3c ) and reduced translocation of PKC␦, -⑀, and - (Figure 3d ). Specific downregulation of PLD2 To confirm this finding and to assess PKC isozyme speciwith the corresponding antisense oligonucleotide to PLD2 ficity in more detail, the effect on receptor-coupled PKC had no effect on PKC activity or isozyme translocation. translocation to the membrane was assessed in cells incuTherefore, PLD1 and not PLD2 appears to couple Fc␥RI bated with 0.3% butan-1-ol compared with cells incubated to the activation of PKCs and, consistent with the findings with the same concentration of butan-2-ol. Translocation described above, Fc␥RI activation of PKC activity in of the three PKCs, ␦, ⑀, and , was abolished in cells these cells appears to be dependent on and lie downpretreated with 0.3% butan-1-ol but not in cells preincustream of PLD activation. bated with butan-2-ol (Figure 3b) . Thus, the three PKC isozymes known to translocate to the membrane following In summary, we have shown here that activation of the Fc␥RI aggregation are dependent on PLD-derived phosreceptor Fc␥RI by surface immune complexes on IFNphatidic acid. PKC␣ is found to be constitutively present ␥-primed U937 cells stimulates the association of PLD1 in the membrane fraction in these cytokine-primed cells, with ARF6 and PKC␣ independent of PKC kinase activand no further translocation can be observed following ity. All the observed Fc␥RI-mediated increase in PKC Fc␥RI aggregation [8] .
activity requires PLD1 isozyme activity. PLD activation generates a variety of intracellular signaling molecules. The regulatory domains of PKCs are diverse; different
The activation of different PKC isozymes downstream of isozymes are likely to influence PLD activity to varying PLD activation through potentially different mechanisms degrees. The role of the novel and atypical PKCs in reguprovides evidence for the generation of diverse responses lating PLD has not been defined, and our data here indiin this system. The potential diversity offers the opportucate that PKC␦, -⑀, and -do not play a role. Rather, nity within the cell to regulate very precisely differential we show here that all Fc␥RI-mediated PKC activity was signal transduction cascades. dependent on PLD-derived phosphatidic acid, indicating that PLD activity lies upstream of PKC activity in these cies generated by PC-PLD/PA hydrolase differs from that derived by phospholipase C hydrolysis of phosphatidyl
